Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousPenile ImplantationTransplantation, HomologousStem CellsStem Cell TransplantationHematopoietic Stem CellsBlood BanksTransplantation ConditioningGraft vs Host DiseaseAntigens, CD34Hematologic NeoplasmsHematopoietic Stem Cell MobilizationBone Marrow TransplantationGranulocyte Colony-Stimulating FactorGraft SurvivalSpinal CordLeukapheresisCell DifferentiationMelphalanCombined Modality TherapyTreatment OutcomeTransplantation ChimeraMice, SCIDBusulfanTissue DonorsCells, CulturedMyeloablative AgonistsMultiple MyelomaBlood Component RemovalCyclophosphamideRecurrenceHistocompatibility TestingRemission InductionAntineoplastic Combined Chemotherapy ProtocolsSpinal Cord InjuriesWhole-Body IrradiationHistocompatibilityLeukemiaMice, Inbred NODLymphoma, Non-HodgkinHematopoiesisRetrospective StudiesImmunosuppressive AgentsLiver TransplantationVidarabineGraft vs Leukemia EffectAntineoplastic Agents, AlkylatingTime FactorsMesenchymal Stem Cell TransplantationDisease-Free SurvivalEtoposideBlood CellsSurvival RateThiotepaInfectionTransplantation, IsogeneicSurvival AnalysisUmbilical CordLeukemia, Myeloid, AcuteSalvage TherapyHematologic DiseasesCell TransplantationAdult Stem CellsHLA AntigensHodgkin DiseasePOEMS SyndromeMyelodysplastic SyndromesAnemia, AplasticAmyloidosisCytarabineEmbryonic Stem CellsInfant, NewbornFollow-Up StudiesImmunophenotypingCytomegalovirus InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow CellsT-LymphocytesKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Cell Count